Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2017Radiation OncologyOpen Access

A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

YXYi XiaNanchang UniversityYLYunhai LiThe University of Texas MD Anderson Cancer CenterYCYun ChenTokyo University of Information Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xia et al. (2017) studied this question.

synapsesocial.com/papers/6a760c75b23c009ac9fbd643https://doi.org/10.1186/s13014-017-0785-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma2013 · 47 citations
  2. 2A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma2014 · 30 citations
  3. 3Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus1994 · 289 citations
  4. 4Chemoradiotherapy of Locally Advanced Esophageal Cancer1999 · 1,974 citations
  5. 5Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus1999 · 444 citations